Admission is currently being canceled due to the professor's circumstances.
If you only need the materials, please let us know.

Complementary and Alternative Medicine for Naturopathy

Integrative Oncology and others.

(Special course for career-building  persons) First shot

 

Recruitment of 10 people in 2024-25.

 

Diploma in Integrative Oncology.
TOWARDS UNDERSTANDING THE PROS AND CONS OF VARIOUS TREATMENT OPTIONS FOR CANCER: A FRONT-LINE SCIENCE BASED COURSE FOR ALL HEALTH PRACTITIONERS, CANCER PATIENTS AND STUDENTS OF THE HEALTH SCIENCES.

By  Ph.D. Peter H Kay. (Australian trained Molecular Pathologist, Immunopathologist and Cancer Specialist).

About the course.

 

Course outline

１．CERTIFICATION IN INTEGRATIVE ONCOLOGY.

２．CERTIFICATION IN INTEGRATIVE IMMUNOPATHOLOGY.

​３．HOW TO BECOME A SUCCESSFUL RESEARCH SCIENTIST

This unique course has been prepared to enable all health carers to provide a much-needed life-saving information and support service to those who suffer from cancer. The course includes easily understandable information about factors which influence the development, progression and treatment of cancer as well as basic dietary considerations. This course is also of great benefit to patients who wish to understand more about the basics of cancer and the pros and cons of alternative treatments.
 

Chemotherapy as well as radiotherapy and surgery remain frontline treatments for cancer, however, many chemotherapeutic drugs, when absorbed into the bloodstream need to be activated by certain enzymes before they can be of help to the patient. In some cases, chemotherapy drugs may be quite harmful if the patient has inherited a particular form of a drug activating enzyme that activates a drug either too quickly or too slowly. Furthermore, some patients may be severely harmed or even die if they have inherited a type of gene that is involved in metabolism of some chemotherapeutic drugs.

 

Cancer cells in around half of all cancer cases develop multi-drug resistance. When this happens, chemotherapeutic drugs do not work. The mechanism and significance of multi-drug resistance is discussed in the course.
Another important consideration with respect to determining the effectiveness of chemotherapy or radiotherapy involves the genetic status of a gene called TP53. Around half of all cancer cells have developed a mutant form of the TP53 gene. Recent studies have shown that the presence of mutant forms of TP53 may reduce the benefits of chemotherapy and radiotherapy. Implications with respect to TP53 genetics are discussed in detail in the course.
 

In recent times, remarkable new treatments have been developed by harnessing elements of the immune system. These immune based treatments
avoid many of the problems associated with chemotherapy and radiotherapy. Exciting new immune based anti-cancer treatments such as CAR-T cell therapy and immune checkpoint therapy are detailed in the course.
 

It is now clear that certain viruses are responsible for development of cancer. Remarkably, one particular virus which can cure cancer has been discovered. The role of viruses with respect to development and resolution of cancer is introduced in the course.
Many cancer cells develop an unusual metabolic pathway that can be targeted. This course introduces the participant to dietary changes or other ways that can be applied to counter this cancer cell specific metabolic or glycolytic pathway.
 

I have prepared this course based on past and present advances to provide a wide range of genetic, biochemical, metabolic and immunological information to patients, practitioners and students of science to enable them to understand many aspects of the development, progression and treatment of cancer.

​​​